Peter Van der Meer Selected Research

Peter Van der Meer Research Topics

5	Heart Failure 01/2024 - 09/2017
3	Neoplasms (Cancer) 01/2024 - 01/2019
2	Cardiotoxicity 01/2024 - 01/2019
2	Iron Deficiencies 01/2019 - 09/2017
1	Second Primary Neoplasms (Neoplasms, Second) 01/2024
1	Body Weight (Weight, Body) 09/2023
1	Obesity 09/2023
1	Weight Loss (Weight Reduction) 09/2023
1	Hemorrhage 01/2021
1	Stroke (Strokes) 01/2021
1	Chronic Renal Insufficiency 01/2019
1	Atrial Fibrillation 11/2018

1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024
1	semaglutideIBA 09/2023
1	C-Reactive ProteinIBA 09/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 08/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021
1	AnticoagulantsIBA 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	Phosphates (Orthophosphate)IBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Erythropoietin FDA Link 01/2019
1	Fibroblast Growth Factor-23IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	Transferrin (beta 2 Transferrin)IBA 09/2017
1	IronIBA 09/2017
1	Ferritins (Ferritin)IBA 09/2017